BH3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PTC Therapeutics Inc

Watchlist Manager

Watchlist

Price: 68.58 EUR 1% Market Closed

Market Cap: €5.3B

	PTC Therapeutics Inc F:BH3	US
B	Berkshire Hathaway Inc F:BRH	US
D	Diageo PLC BMV:DEON	UK
D	Diebold Nixdorf Inc F:DBD	US

Profitability Summary

PTC Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

94%

Declining Gross Margin

94% > 92%

Negative Operating Margin

-8%

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-62% > -8%

Negative Net Margin

-23%

Negative 3Y Average Net Margin

-25%

Net Margin is Increasing

-74% > -23%

Negative Free Cash Flow Margin

-27%

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

-42% > -27%

Exceptional ROE

102%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

25%

ROIC is Increasing

-39% > -8%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.